Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection: A rare complication

被引：0
|
作者：
Sahidt Ortega-Ibarra, Felipe
Maria Remes-Troche, Jose
机构：
来源：
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2013年 / 105卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：291 / 292
页数：2
相关论文
共 50 条
  • [31] Severe muscle weakness during treatment with pegylated interferon alfa for chronic hepatitis C virus infection; A rare complication
    Mobini, Maryam
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2010, 1 (03) : 111 - 114
  • [32] Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C
    Watanabe, Masaaki
    Ogasawara, Sumie
    Takahashi, Akihiko
    Takada, Juichi
    Tanaka, Yoshiaki
    Okuwaki, Yusuke
    Minamino, Tsutomu
    Hidaka, Hisashi
    Nakazawa, Takahide
    Shibuya, Akitaka
    Koizumi, Wasaburo
    CUTANEOUS AND OCULAR TOXICOLOGY, 2012, 31 (03) : 253 - 257
  • [33] Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin
    Fujita, N.
    Kaito, M.
    Kai, M.
    Sugimoto, R.
    Tanaka, H.
    Horiike, S.
    Konishi, M.
    Iwasa, M.
    Watanabe, S.
    Adachi, Y.
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (07) : 441 - 448
  • [34] Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin
    Ei Tae Kim
    Lee Hoo Kim
    Jung Il Lee
    Hee Seung Chin
    Japanese Journal of Ophthalmology, 2009, 53 : 598 - 602
  • [35] Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection
    Pawlotsky, Jean-Michel
    Flisiak, Robert
    Sarin, Shiv K.
    Rasenack, Jens
    Piratvisuth, Teerha
    Chuang, Wan-Long
    Peng, Cheng-Yuan
    Foster, Graham R.
    Shah, Samir
    Wedemeyer, Heiner
    Hezode, Christophe
    Zhang, Wei
    Wong, Kelly A.
    Li, Bin
    Avila, Claudio
    Naoumov, Nikolai V.
    HEPATOLOGY, 2015, 62 (04) : 1013 - 1023
  • [36] Advantage of pegylated interferon and ribavirin combination therapy in people living with hepatitis C virus/HIV coinfection
    Qadir, Muhammad Imran
    Arooj, Javaria
    REVIEWS IN MEDICAL MICROBIOLOGY, 2016, 27 (01) : 9 - 12
  • [37] Impact of Ribavirin Dosage in Chronic Hepatitis C Patients Treated With Simeprevir, Pegylated Interferon Plus Ribavirin Combination Therapy
    Tahata, Yuki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Urabe, Ayako
    Morishita, Naoki
    Yamada, Ryoko
    Yakushijin, Takayuki
    Hosui, Atsushi
    Oshita, Masahide
    Kaneko, Akira
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Yamada, Yukinori
    Inada, Masami
    Katayama, Kazuhiro
    Tamura, Shinji
    Imai, Yasuharu
    Hikita, Hayato
    Sakamori, Ryotaro
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Hayashi, Norio
    Takehara, Tetsuo
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (10) : 1776 - 1784
  • [38] Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin
    Kim, Ei Tae
    Kim, Lee Hoo
    Lee, Jung Il
    Chin, Hee Seung
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (06) : 598 - 602
  • [39] Combination therapy with pegylated interferon plus ribavirin in the treatment of hepatitis C virus-related thrombocytopenia
    Karakan, T
    Cindoruk, M
    Degertekin, B
    Dogan, I
    Sancak, A
    Dumlu, S
    Gorgul, A
    Unal, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (03): : 247 - 253
  • [40] Therapy Induced Anemia in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon Alpha and Ribavirin
    Mehdi, Syed Ghazanfar
    Faizi, Karim Shah
    Khan, Rao Saad Ali
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (01): : 204 - 206
12345